Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms

BACKGROUND: Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA). CASE PRESENTATION: We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of the lite...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatr Rheumatol Online J
Hauptverfasser: Halyabar, Olha, Friedman, Kevin G., Sundel, Robert P., Baker, Annette L., Chang, Margaret H., Gould, Patrick W., Newburger, Jane W., Son, Mary Beth F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968156/
https://ncbi.nlm.nih.gov/pubmed/33731148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-021-00526-0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge